echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Turnstone Biologics reached a partnership to develop tumor infiltrating lymphocyte therapy

    Turnstone Biologics reached a partnership to develop tumor infiltrating lymphocyte therapy

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Turnstone Biologics announced that it has reached a multi-year strategic research cooperation with Moffitt Cancer Center to jointly conduct research on tumor infiltrating lymphocyte (TIL) therapy


    TIL is a lymphocyte that migrates into the tumor when cancer occurs and attacks the tumor


    Turnstone’s unique technology platform will discover tumor-related T cells in TIL, combined with advanced cell screening and culture technology, to quickly enrich T cells that eliminate tumors and preserve the diversity of T cell targeted antigens.


    ▲Turnstone's TIL technology platform (picture source: Turnstone official website)

    According to the agreement, Moffitt will collaborate to discover, enrich and expand TILs that recognize neoantigens in a variety of solid tumors, including melanoma, breast cancer, and rectal cancer


    Reference materials:

    [1] Turnstone Biologics Announces Research Collaboration with Moffitt Cancer Center to Advance Novel TIL Immunotherapies for Solid Tumor Indications.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.